---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-246973"
form_type: "8-K"
ticker: "AMRN"
cik: "0000897448"
company_name: "AMARIN CORP PLCUK"
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:55:07.084950+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Amarin promotes David Keenan to EVP, COO effective October 17, 2025

## Summary
- David Keenan, previously EVP Technical Operations and President of Europe, appointed COO effective Oct 17, 2025.
- Dr. Keenan joined Amarin in May 2022 as SVP Technical Operations; promoted to EVP in July 2023.
- No change to compensation as a result of the COO appointment; no family relationships or arrangements.
- Keenan brings over 30 years leadership in biopharma; holds PhD in Organic Chemistry and MBA.

## SEC filing metadata
- accession: 0001193125-25-246973
- form_type: 8-K
- ticker: AMRN
- cik: 0000897448
- company_name: AMARIN CORP PLCUK
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/897448/000119312525246973/0001193125-25-246973-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/897448/000119312525246973/amrn-20251017.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-246973
- JSON: https://secwatch.observer/filing/0001193125-25-246973.json
- Plain text: https://secwatch.observer/filing/0001193125-25-246973.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.